FDA Investigator Temar Q Williams

Temar Q Williams has conducted inspections on 31 sites in 6 countries as of 15 May 2017. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
31
Last Inspection Date:
15 May 2017
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Ireland, China, Italy, Germany, France
FDA Investigators that have inspected at least one site in common with Temar Q Williams:
Alan P Kurtzberg, Alberto A Viciedo, Anastasia I Onuorah, Anastasia M Shields, Anita R Michael, Ann Marie Montemurro, Annemarie Bodnar, Anthony A Charity, Anthony F Lorenzo, Arthur T Ogdahl, Audrey Thereset Uy, Bonita S Chester, Brian R Yaun, Brooke K Higgins, Brooke K Seeman, Bruce H Mccullough, Burnell M Henry, Camerson E Moore, Candice C Mandera, Candice J Cortes, Carl Lee, Carla A Norris, Caryn M Mcnab, Cassandra L Abellard, CDR Ileana Barreto Pettit, Charles M Edwards, Christian D Lynch (CDL), Christopher R Czajka, Christopher S Keating, Christopher T Peters, Colleen M Damon, Craig D Zagata, David A Oluwo, David M Beltran, Debra J Bennett, Debra L Pagano, Demitria J Xiradakis, Denise M Digiulio, Dennis Cantellops Paite, Donna Ltartaglino Besone, Donna Mwilliams Hill, PhD, Douglas A Campbell, Douglas C Kovacs, Dr. Barbara D Paul, PhD, Dr. Gang Wang, PhD, Edwin Martinez, Emest F Bizjak, Emily J Orban, Eric L Dong, BS, Eric M Mueller, PharmD, Erika E Englund, PhD, Erika V Butler, Erin C Hill, Felix Maldonado, Francis A Guidry, Frank W Perrella, Gayle S Lawson, George Pyramides, Gerald B Seaborn, Jr, Gwyn G Dickinson, H Ljamilla Selby, Hala L Selby, Hala Lj Whetstone, Helen B Ricalde, Heriberto Negron Rivera, Ivan E Reyes, Jacqueline Mdiaz Albertini, Jaison J Eapen, James A Beaulieu, James C Illuminati, James C Maclaughlin, James L Dunnie, Jr, James M Mason, James P Mcevoy, James R Birkenstamm, Jason F Chancey, Javier E Santos, Jean Blackston Hill, Jeen S Min, Jeffery A Hangartner, Jeffrey A Sommers, Jennifer J Stone, Jessica L Pressley, Joan A Loreng, Joanne E King, Joanne Heim, Joanne M Hajoway, John A Gonzalez, John D White, Jonathan W Chapman, Jose A Lopez, Jose Acruz Gonzalez, José E Meléndez, Jose R Hernandez, Joseph L Despins, PhD, Joshua J Silvestri, Julianne C Mccullough, Julie D Bringger, Junho Pak, Justin A Boyd, Justine Tomasso, Karthik B Iyer, Karyn M Campbell, Kelli F Dobilas, Kelly I Anderson, Kendra L Brooks, Kenneth Nieves, Kham Phommachanh, Kim Lthomas Cruse, Ko U Min, Kristen D Evans, Kristina J Donohue, Kristina L Conroy, Kristina Mjoyce Pittman, Kristy A Zielny, Lane V Christensen, PhD, Larry K Austin, Lawrence J Stringer, LCDR Chad N Thompson, LCDR Debra Emerson, LCDR Susan E Polifko, Linda M Hoover, Lisa B Orr, Lisa M Bellows, Lixia Cai, Luella J Rossi, Luis A Dasta, Lydia I Rosas Marty, Marcus A Ray, Marcus F Yambot, Marea K Harmon, Margaret M Annes, Marie F Morin, Marijo B Kambere, PhD, Mark R Mcclain, Mary Davis Lopez, Mary E Storch, Matthew B Casale, Matthew R Noonan, Megan A Haggerty, Meisha R Sampson, Melissa J Garcia, Michael A Charles, Michael A Taylor, Michael E Maselli, Michael Gurbarg, Michael L Casner, Michael L Chasey, Michele M Falchek, Mihaly S Ligmond, Monika Borkowska, Mra B Kamberem, Mra Mcculloughj, Mra Munizn, Nawab A Siddiqui, Nebil A Oumer, Nibin Varghese, MS, Nicholas L Paulin, Niketa Patel, Nikhil Thakur, Parul M Patel, Paul L Bellamy, Paula A Trost, Philip F Istafanos, DMV, MS, Qin Xu, Rabin N Ghoshal, Rachel C Harrington, Raymond T Oji, Rebecca Rodriguez, Reginald D Neal, Richard E Needham, Richard K Vogel, Richard Ledwidge (nmi), PhD, Robert B Shibuya, MD, Robert D Tollefsen, Robert J Maffei, Robert J Martin, Robert L Stevenson, Robin Levis, PhD, Robin P Mathew, Rochelle L Campbell, Rochelle L Cross, Roger F Zabinski, Rose Ashley, Rose Ljean Mary, Rumany C Penn, PharmD, Saleem A Akhtar, Sam Pepe, Sangeeta M Khurana, PhD, Santos E Camara, Sharon K Thoma, PharmD, Sidney B Priesmeyer, Stephen D Brown, Stephen J Koniers, Stephen R Souza, Steven D Kehoe, Steven J Thurber, Steven M Weinman, Steven P Donald, Susan F Laska, MS, Susan M Jackson, Susan W Ting, Swati Verma, Tamil Arasu, PhD, Tammy L Chavis, Tara G Bizjak, Tara R Gooen, Terri L Dodds, Thai D Truong, Thomas E Friel, Thomas R Withers, Tracey L Harris, Truong Xuan Nguyen (Andy), Viviana Matta, Viviana R Ramirez, Vlada Matusovsky, Walden H Lee, Wayne E Seifert, Yasamin Ameri, Yvonne C Mcknight, Yvonne C Wood

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more